Literature DB >> 1877710

Dengue-1 virus envelope glycoprotein gene expressed in recombinant baculovirus elicits virus-neutralizing antibody in mice and protects them from virus challenge.

R Putnak1, R Feighny, J Burrous, M Cochran, C Hackett, G Smith, C Hoke.   

Abstract

In order to test the feasibility of baculovirus (Autographa californica nuclear polyhedrosis virus, AcNPV) expression vectors for making immunogens against dengue-1 (DEN-1) virus, a portion of the envelope (E) glycoprotein gene of DEN-1 virus was cloned and expressed. The recombinant baculovirus contains 107 nucleotides from the 3' terminus of the DEN-1 matrix (M) gene, which encodes a hydrophobic signal peptide and extends through the first 1, 245 nucleotides of E, terminating 243 nucleotides before the 3' terminus of E. When the recombinant virus was grown in Spodoptera frugiperda cells, about 1 mg of E antigen was made per 10(9) cells. Recombinant E antigen reacted with E protein-specific monoclonal antibodies and stimulated production of DEN-1 virus neutralizing antibody in BALB/c mice. Mice immunized with recombinant E antigen or with heat-inactivated DEN-1 virus were protected significantly against lethal DEN-1 virus challenge. A dose/response effect was observed, with increasing amounts of recombinant antigen leading to increased survival. These results demonstrate the utility of baculovirus for producing immunogens against DEN-1 virus.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1877710     DOI: 10.4269/ajtmh.1991.45.159

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  10 in total

1.  Use of recombinant envelope proteins for serological diagnosis of Dengue virus infection in an immunochromatographic assay.

Authors:  A J Cuzzubbo; T P Endy; A Nisalak; S Kalayanarooj; D W Vaughn; S A Ogata; D E Clements; P L Devine
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

2.  Epitope mapping of dengue 1 virus E glycoprotein using monoclonal antibodies.

Authors:  E Simantini; K Banerjee
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

Review 3.  The development of recombinant subunit envelope-based vaccines to protect against dengue virus induced disease.

Authors:  Beth-Ann G Coller; David E Clements; Andrew J Bett; Sangeetha L Sagar; Jan H Ter Meulen
Journal:  Vaccine       Date:  2011-07-21       Impact factor: 3.641

4.  A recombinant West Nile virus envelope protein vaccine candidate produced in Spodoptera frugiperda expresSF+ cells.

Authors:  Nathalie Bonafé; Joseph A Rininger; Richard G Chubet; Harald G Foellmer; Stacey Fader; John F Anderson; Sandra L Bushmich; Karen Anthony; Michel Ledizet; Erol Fikrig; Raymond A Koski; Paul Kaplan
Journal:  Vaccine       Date:  2008-11-07       Impact factor: 3.641

5.  Glycoprotein E2 of bovine viral diarrhea virus expressed in insect cells provides calves limited protection from systemic infection and disease.

Authors:  S R Bolin; J F Ridpath
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

6.  Development of a recombinant tetravalent dengue virus vaccine: immunogenicity and efficacy studies in mice and monkeys.

Authors:  David E Clements; Beth-Ann G Coller; Michael M Lieberman; Steven Ogata; Gordon Wang; Kent E Harada; J Robert Putnak; John M Ivy; Michael McDonell; Gary S Bignami; Iain D Peters; Julia Leung; Carolyn Weeks-Levy; Eileen T Nakano; Tom Humphreys
Journal:  Vaccine       Date:  2010-01-22       Impact factor: 3.641

Review 7.  The use of baculoviruses as expression vectors.

Authors:  I M Kidd; V C Emery
Journal:  Appl Biochem Biotechnol       Date:  1993 Aug-Sep       Impact factor: 2.926

8.  Protective efficacy in mice of a secreted form of recombinant dengue-2 virus envelope protein produced in baculovirus infected insect cells.

Authors:  C Delenda; M P Frenkiel; V Deubel
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

9.  The complexity of antibody-dependent enhancement of dengue virus infection.

Authors:  Maria G Guzman; Susana Vazquez
Journal:  Viruses       Date:  2010-12-08       Impact factor: 5.048

10.  An adenovirus prime/plasmid boost strategy for induction of equipotent immune responses to two dengue virus serotypes.

Authors:  Saima Khanam; Pilankatta Rajendra; Navin Khanna; Sathyamangalam Swaminathan
Journal:  BMC Biotechnol       Date:  2007-02-15       Impact factor: 2.563

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.